These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 15126270)

  • 1. Summaries for patients. The cost-effectiveness of screening for type 2 diabetes.
    Ann Intern Med; 2004 May; 140(9):I29. PubMed ID: 15126270
    [No Abstract]   [Full Text] [Related]  

  • 2. Screening for type 2 diabetes mellitus: a cost-effectiveness analysis.
    Hoerger TJ; Harris R; Hicks KA; Donahue K; Sorensen S; Engelgau M
    Ann Intern Med; 2004 May; 140(9):689-99. PubMed ID: 15126252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for diabetes: can we afford not to screen?
    Nathan DM; Herman WH
    Ann Intern Med; 2004 May; 140(9):756-8. PubMed ID: 15126261
    [No Abstract]   [Full Text] [Related]  

  • 4. Cost-effectiveness of screening and optimal management for diabetes, hypertension, and chronic kidney disease: a modeled analysis.
    Howard K; White S; Salkeld G; McDonald S; Craig JC; Chadban S; Cass A
    Value Health; 2010; 13(2):196-208. PubMed ID: 19878493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of coronary artery disease screening in asymptomatic patients with type 2 diabetes and other atherogenic risk factors in Japan: factors influencing on international application of evidence-based guidelines.
    Hayashino Y; Shimbo T; Tsujii S; Ishii H; Kondo H; Nakamura T; Nagata-Kobayashi S; Fukui T
    Int J Cardiol; 2007 May; 118(1):88-96. PubMed ID: 16949690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of screening strategies to detect heart failure in patients with type 2 diabetes.
    van Giessen A; Boonman-de Winter LJ; Rutten FH; Cramer MJ; Landman MJ; Liem AH; Hoes AW; Koffijberg H
    Cardiovasc Diabetol; 2016 Mar; 15():48. PubMed ID: 27001409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Summaries for patients. The cost-effectiveness of strategies to prevent type 2 diabetes.
    Ann Intern Med; 2005 Mar; 142(5):I28. PubMed ID: 15738446
    [No Abstract]   [Full Text] [Related]  

  • 8. A French cost-consequence analysis of the renoprotective benefits of irbesartan in patients with type 2 diabetes and hypertension.
    Palmer AJ; Valentine WJ; Tucker DM; Ray JA; Roze S; Annemans L; Lapuerta P; Chen R; Gabriel S; Carita P; Rodby RA; de Zeeuw D; Parving HH; Laville M
    Curr Med Res Opin; 2006 Nov; 22(11):2095-100. PubMed ID: 17076969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of a National Telemedicine Diabetic Retinopathy Screening Program in Singapore.
    Nguyen HV; Tan GS; Tapp RJ; Mital S; Ting DS; Wong HT; Tan CS; Laude A; Tai ES; Tan NC; Finkelstein EA; Wong TY; Lamoureux EL
    Ophthalmology; 2016 Dec; 123(12):2571-2580. PubMed ID: 27726962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for proteinuria in US adults: a cost-effectiveness analysis.
    Boulware LE; Jaar BG; Tarver-Carr ME; Brancati FL; Powe NR
    JAMA; 2003 Dec; 290(23):3101-14. PubMed ID: 14679273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Summaries for patients. The cost-effectiveness of full Medicare coverage of angiotensin-converting enzyme inhibitors for patients with diabetes.
    Ann Intern Med; 2005 Jul; 143(2):I21. PubMed ID: 16027445
    [No Abstract]   [Full Text] [Related]  

  • 12. Cost-effectiveness of full medicare coverage of angiotensin-converting enzyme inhibitors for beneficiaries with diabetes.
    Rosen AB; Hamel MB; Weinstein MC; Cutler DM; Fendrick AM; Vijan S
    Ann Intern Med; 2005 Jul; 143(2):89-99. PubMed ID: 16027450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Summaries for patients. Cost-effectiveness of screening and surveillance for Barrett esophagus.
    Ann Intern Med; 2003 Feb; 138(3):I-41. PubMed ID: 12558382
    [No Abstract]   [Full Text] [Related]  

  • 14. Cost-effectiveness of screening for coronary artery disease in asymptomatic patients with Type 2 diabetes and additional atherogenic risk factors.
    Hayashino Y; Nagata-Kobayashi S; Morimoto T; Maeda K; Shimbo T; Fukui T
    J Gen Intern Med; 2004 Dec; 19(12):1181-91. PubMed ID: 15610328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How frequently should patients with type 2 diabetes mellitus be screened for retinopathy?
    Murphy C; Newton W
    J Fam Pract; 2000 May; 49(5):395-6. PubMed ID: 10836765
    [No Abstract]   [Full Text] [Related]  

  • 16. A health economic analysis of screening and optimal treatment of nephropathy in patients with type 2 diabetes and hypertension in the USA.
    Palmer AJ; Valentine WJ; Chen R; Mehin N; Gabriel S; Bregman B; Rodby RA
    Nephrol Dial Transplant; 2008 Apr; 23(4):1216-23. PubMed ID: 18359872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-Effectiveness of Screening for Intermediate Age-Related Macular Degeneration during Diabetic Retinopathy Screening.
    Chan CK; Gangwani RA; McGhee SM; Lian J; Wong DS
    Ophthalmology; 2015 Nov; 122(11):2278-85. PubMed ID: 26315045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of telemedicine for screening of diabetic retinopathy in the Veterans Health Administration.
    Kirkizlar E; Serban N; Sisson JA; Swann JL; Barnes CS; Williams MD
    Ophthalmology; 2013 Dec; 120(12):2604-2610. PubMed ID: 24084501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic evaluation of ASCOT-BPLA: antihypertensive treatment with an amlodipine-based regimen is cost effective compared with an atenolol-based regimen.
    Lindgren P; Buxton M; Kahan T; Poulter NR; Dahlöf B; Sever PS; Wedel H; Jönsson B;
    Heart; 2008 Feb; 94(2):e4. PubMed ID: 17916665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of type 2 diabetes screening: results from recently published studies.
    Icks A; Rathmann W; Haastert B; John J; Löwel H; Holle R; Giani G;
    Gesundheitswesen; 2005 Aug; 67 Suppl 1():S167-71. PubMed ID: 16032536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.